&bgr;3-Adrenergic Receptors: Really Relevant Targets for Anti-Obesity Drugs?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6158|3|3|257-273

ISSN： 1568-0150

Source： Current Medicinal Chemistry - Central Nervous System Agents, Vol.3, Iss.3, 2003-09, pp. : 257-273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of &bgr;2-Adrenergic Receptors in Inflammation and Allergy

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 2, 2005-04 ,pp. : 157-162

Bentham Science Publishers

Access to resources Recommend Favorite

The Saccharomyces cerevisiae GSK-3&bgr; Homologs

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1455-1465

Bentham Science Publishers

Access to resources Recommend Favorite

Hypothalamic Neuropeptide Systems as Targets for Potential Anti-Obesity Drugs

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 1, 2007-01 ,pp. : 11-19

Bentham Science Publishers

Access to resources Recommend Favorite

Novel anti-obesity drugs

By Proietto J.   Fam B.C.   Ainslie D.A.   Thorburn A.W.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 6, 2000-06 ,pp. : 1317-1326

Informa Healthcare

Access to resources Recommend Favorite

Beta3 -Adrenoceptor Agonists as Anti-diabetic and Anti-obesity Drugs in Humans

By  

Current Pharmaceutical Design, Vol. 7, Iss. 14, 2001-09 ,pp. : 1433-1449

Bentham Science Publishers

Access to resources Recommend Favorite